Andersen, J. B. Et Al. 2021. The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.53 .

Andersen, J. B., Sharmin, S., Lefort, M., Koch-Henriksen, N., Sellebjerg, F., Sorensen, P. S., ... Christensen, C. C. H.(2021). The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies. MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.53.

Andersen, Johanna Et Al. "The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies," MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.53, 2021

Andersen, Johanna B. Et Al. "The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.53, 2021

Andersen, J. B. Et Al. (2021) . "The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies." MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.53.

@article{article, author={Johanna B. Andersen Et Al. }, title={The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies}, journal={MULTIPLE SCLEROSIS AND RELATED DISORDERS}, year=2021}